The interim CEO and director of drugmaker Kenvue, which makes the frequent ache reliever Tylenol, met with US Health and Human Services Secretary Robert F. Kennedy Jr. privately this week in an try to dissuade him from together with the drug as a possible trigger of autism in an upcoming report, the Wall Street Journal reported Friday.
HHS officers have introduced that the division is conducting a research of the causes of autism, and latest reports recommend that HHS will difficulty an evaluation that hyperlinks the event of autism to the mom’s use of Tylenol throughout being pregnant, amongst different potential causes. The report is anticipated to be launched this month.
Tylenol is a model title for the ache reliever acetaminophen.
The American College of Obstetricians and Gynecologists has stated that there is no proof of a causal link between Tylenol use in being pregnant and a toddler’s prognosis of autism.
In an announcement Friday, a spokesperson for HHS stated that officers routinely meet with stakeholders for his or her views.
“We are using gold-standard science to get to the bottom of America’s unprecedented rise in autism rates. HHS officials regularly meet with stakeholders to get their perspective about our agenda to Make America Healthy Again. Any claims regarding this or any other specific meeting, however, are nothing more than speculation unless officially discussed by HHS,” HHS spokesperson Andrew Nixon stated.
Kenvue stated in its personal assertion Friday that it engaged in a “scientific exchange” with HHS officers however that it is involved in regards to the forthcoming HHS report probably inflicting confusion.
“As we would with any regulator who reaches out to us, we engaged in a scientific exchange with the Secretary and members of his staff as it relates to the safety of our products. Our position remains the same: in evaluating available science, we continue to believe that taking acetaminophen does not cause autism, and global health regulators, independent public health organizations, and medical professionals agree,” Kenvue stated.
“We are concerned about the potential for consumer confusion and misinformation about the safety of taking acetaminophen during pregnancy, particularly as cough, cold and flu season approaches,” the assertion stated. “We encourage regulators to continue to objectively review the scientific evidence on this issue, as they have done for many years. FDA has been looking at this issue for over a decade and has conducted multiple reviews since 2014 and continues to recommend acetaminophen in pregnancy and maintain the same labeling requirements.”
The firm additionally really helpful that anticipating moms communicate to their well being care supplier earlier than taking any over-the-counter drugs, together with acetaminophen, which is additionally indicated on the product label.
Tylenol is broadly used within the US, together with throughout being pregnant. The US Food and Drug Administration recommends towards utilizing different frequent ache relievers, nonsteroidal anti-inflammatory medication, in being pregnant at 20 weeks or later as a result of they can lead to low amniotic fluid.
“There is no clear evidence that proves a direct relationship between the prudent use of acetaminophen during pregnancy and fetal developmental issues,” Dr. Christopher Zahn, chief of medical observe for the American College of Obstetricians and Gynecologists, stated in an announcement this month. “Neurodevelopmental disorders, in particular, are multifactorial and very difficult to associate with a singular cause. Pregnant patients should not be frightened away from the many benefits of acetaminophen, which is safe and one of the few options pregnant people have for pain relief.”